RE:Appoints Matthew J. Pietras as CFO and COOsounds like a very experienced addition to SZLS management team. More to come.
"StageZero Life Sciences is at an exciting and important turning point in its history," said Pietras. "The planned acquisition and integration of Care Oncology promises to be transformative and will provide the Company with multiple revenue streams. I am looking forward to leveraging my financial and operational experience to help the management team position StageZero Life Sciences for long-term growth and profitability."
Pietras brings two decades of financial executive experience, primarily at life science companies. Prior to joining StageZero Life Sciences, he was Vice President of Finance at Maryland-based CiVi Biopharma, where he was responsible for the oversight of Finance and Operations. Prior to that, he was Corporate Treasurer and Controller of Viela Bio from 2017 through 2019. At Viela Bio, the spin-out of AstraZeneca's AutoImmune Franchise, he was responsible for the design and implementation of the financial operations and preparing the company for its eventual IPO. From 2013 through 2017, he held senior finance roles at AstraZeneca/Medimmune, culminating in his position as Global Therapeutic Area Finance Director for the company's Oncology portfolio. He also held finance roles at Wells Fargo, Wachovia, and KPMG. He holds a B.S. in accounting and a B.S. in international business from Pennsylvania State University, and an M.S. in biotechnology and an MBA from Johns Hopkins University. Pietras is also a Certified Public Accountant.